ArticleJournal of neuro-oncology2025
Population-based histologic analysis of craniopharyngioma demographics and treatment in the US from 2000 to 2020.
Article in Journal of neuro-oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeCraniopharyngiomas (CP) are rare tumors that serve as a source of significant morbidity despite relatively high survival rates. No analysis based on disease histology has been fully explored.
methodsPatients with CP were identified via the Surveillance, Epidemiology, and End Results (SEER) Program regarding the following ICD-O-3 codes: 9350 (CP, not otherwise specified; NOS), 9351 (adamantinomatous CP; ACP), and 9352 (papillary CP; PCP). Demographic and treatment variables were analyzed via Chi-squared tests and ten-year overall survival (10y OS) was assessed via Cox regression and log-rank analysis.
resultsVariation in 10y OS was seen regarding patient age (p < 0.001), race (p < 0.001), Grade (p = 0.010), stage (p < 0.001), and treatment with radiotherapy (p < 0.001) with Cox regression analysis among the 2,359 patients identified. ACP or CP, NOS histologies were more frequent among patients < 25 years old (p < 0.001), while ACP was more common among male patients (p = 0.002) and PCP was less common among Black patients (p = 0.002). Univariate survival analysis revealed the ACP and CP, NOS histologies had improved 10y OS with treatment with radiotherapy (p < 0.001 and = 0.007, respectively). Finally, surgery was associated with improved 10y OS only among patients with the CP, NOS histology (p = 0.007).
conclusionNo difference in 10-year overall survival was seen regarding histology among diagnosed with craniopharyngioma on multivariate or univariate analysis. Differences in the frequency and survival were found among all three histologies stratified by demographics and treatment. Further investigation into these variables, and among different survival timeframes, is warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.